Abstract:To construct HBV and HCV-specific HLA-A2-peptide tetramers, and to direct clinical therapy.Recombinant class I HLA-A2 heavy chains and beta-2 M were produced in Escherichia coli cells transformed with pBV220 vectors. Only the extracellular domain of class I heavy chain was expressed, following modification by replacement of the C-terminal domain with a substrate sequence for BirA biotinylation. HLA-A2-BSP was folded in the presence of beta-2 microglobulin and a specific peptide to form a peptide-MHC complex. The MHC complexes were biotinylated using purified BirA enzyme. Biotinylated MHC-peptide complexes were purified. Tetramers were generated by mixing biotinylated protein complex with streptavidin-PE at a molar ratio of 4:1. Then analysis of stained PBMCs was performed using FACScan and CellQuest software.The expression levels of pBV220-HLA-A2-BSP and beta-2M were 46% and 48% of total bacterial proteins estimated from SDS - PAGE, respectively. And they were mainly located in the insoluble fraction of the cell as inclusion bodies and the proportion were about 85% and 90%, respectively. The purity of pBV220-HLA-A2-BSP and beta-2M was above 95% analyzed by SDS-PAGE, and the concentration of pBV220-HLA-A2-BSP and beta-2M was about 1.5 g/L and 1.2 g/L, respectively. Using the constructed HLA-A2-peptide tetramer to detect the HBV/HCV-specific CTL, the HBV-specific CD8(+) frequencies were 1.84% and 0.02% - 0.68% of the total CD8(+) T cells in acute and chronic HBV hepatitis, respectively. As an additional control, an HLA-A2/HCV tetramer was tested in the acute and chronic HBV hepatitis. The frequencies never exceeded 0.02% of the total CD8(+) T cell number. Similar low levels of background staining were also detected in the HLA-A2(+) or A2(-) healthy control. The HCV-specific CD8(+) frequency was 0.02 - 0.72% of the total CD8(+) T cells in chronic HCV hepatitis. The same frequencies of control were detected.High-efficient expressions of HLA-A0201-BSP and beta-2m proteins lay a good foundation for further expression and purification in prokaryotic system and constructing MHC class I-peptide tetramer complexes to study the function of CTLs. Especially, using these two HBV and HCV-specific tetramer can detect the frequencies of the HBV/HCV-specific CD8(+) T cells directly in vitro.

[Cloning and Expression of HLA-A*0201-BSP].

Cloning, expression, and purification of HLA-A2-BSP and β-2m in Escherichia coli

Cloning, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coli.

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Cloning of HLA-A * 0201 and Its Transient Expression on COS-7 Cells

In vitro expression and purification of heavy chain and β_2m of soluble HLA-G1

In Vitro Expression and Purification of Heavy Chain and Β2m of Soluble HLA-G1

Cloning, Expression, Purification and Activity of the Hsblys.

In-vitro refolding and biotinylation of soluble HLA-A2-peptide complex]

Recombinant Expression of the<i>β</i>-Subunit of HLA-DR10 for the Selection of Novel Lymphoma Targeting Molecules

Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.

[Cloning, Expression and Identification of Hpaa Gene from a Clinical Isolate of Helicobacter Pylori].

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection]

Construction of HLA-DR1 Expression Vector and Its Expression in Insect Cells

Identification and functional perspective of a novel HLA-A allele: A*0279

Cloning and High Expression of Hbfgf with a New Strategy.

[Cloning Human Heat Shock Protein 90Beta-Cdna and Constructing Its Eukaryon Vector].

[Construction, Identification of Human B7.1 Eukaryotic Expressing Vector and Its Expression on Leukemic Cells].

Expression and Purification of Single-Chain Anti-Hbx Antibody in Escherichia Coli